Compound Detail
CHEMBL1083390
INTEPIRDINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1083390 |
| Name | INTEPIRDINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | JJZFWROHYSMCMU-UHFFFAOYSA-N |
6
Targets
29
Activities
2
Assay Types
7
PK Parameters
20
Publications
6
Known Names
2
Indications
1
Mechanisms
Molecular Properties
353.4
MW (Da)
2.48
ALogP
5
HBA
1
HBD
62.3
PSA (Ų)
0.78
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 6 (5-HT6) receptor antagonist | ANTAGONIST | 5-hydroxytryptamine receptor 6 | ✓ | ✓ |
Indications
Alzheimer Disease Dementia
Activity Summary
Ki 25 meas. best 9.78
IC50 4 meas. best 8.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 9.78 | 9.3413 | 0.2 | 15 |
| 5-hydroxytryptamine receptor 6 CHEMBL3372 | Ki | 9.63 | 9.63 | 0.2 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 8.55 | 8.165 | 2.8 | 4 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 7.6 | 7.59 | 25.1 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 7.58 | 6.2733 | 26.0 | 3 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.0 | 6.0 | 997.0 | 2 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 4.85 | 4.85 | 14230.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 41.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.6 | mL.min-1.g-1 | Rattus norvegicus |
| F | 24.0 | % | Rattus norvegicus |
| F | 76.0 | % | Rattus norvegicus |
| T1/2 | 0.7 | hr | Rattus norvegicus |
| t1/2 | - | - | Rattus norvegicus |
| Vd | 5.7 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| 37797083 | 10.1021/acs.jmedchem.3c01482 | Rattus norvegicus | 17 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 9 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5058564 | U2OS | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| 27326337 | 10.1021/acsmedchemlett.6b00056 | Rattus norvegicus | 5 |
Data from ChEMBL 36 via Core Engine